Significant cognitive decline after VIM or cZi/PSA DBS in ET patients appears to be rare. Future prospective randomized controlled trials are needed to meticulously study the effect of the location, laterality, and stimulation parameters of the active contacts on cognitive outcomes while considering possible medication change post-DBS, timing, standard neuropsychological battery, practice effects, the timing of assessment, and effect size as potential confounders.
Keyphrases
- deep brain stimulation
- cognitive decline
- parkinson disease
- obsessive compulsive disorder
- mild cognitive impairment
- end stage renal disease
- newly diagnosed
- prostate cancer
- randomized controlled trial
- chronic kidney disease
- healthcare
- ejection fraction
- primary care
- peritoneal dialysis
- systematic review
- prognostic factors
- type diabetes
- quality improvement
- adipose tissue
- metabolic syndrome
- emergency department
- adverse drug
- electronic health record